Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.

Therapeutic area

Neurology

How can we help?

26M+

patients with neurological disease

130M+

neuroimaging studies

90M+

neurology clinical notes

Discover more from multimodal, longitudinal neurologic data

Explore symptoms, disease progression, treatment response, and outcomes across the full neurologic patient journey.

Neurovascular diseases

  • Stroke subtype
  • NIHSS scores
  • Modified Rankin Scale scores
  • Recovery trajectories and discharge disposition
  • CT and MRI

Neurodegenerative diseases

  • Cognitive testing
  • Functional outcomes
  • Spine surgery
  • Progression
  • MRI, PET, and CT

Social, behavioral, and familial risk factors

  • Seizure frequency and type
  • Migraine severity and symptom burden
  • Neuromodulation devices
  • EEG, CT, MRI

Neurovascular diseases

Neurodegenerative diseases

Headache and seizure

Neurovascular diseases

Stroke subtype
NIHSS scores
Modified Rankin Scale scores
Recovery trajectories and discharge disposition
CT and MRI

Neurodegenerative diseases

Cognitive testing
Functional outcomes
Spine surgery
Progression
MRI, PET, and CT

Headache and seizure

Seizure frequency and type
Migraine severity and symptom burden
Neuromodulation devices
EEG, CT, MRI

Uncover the complexity of neurologic disease from notes

Truveta brings complete clinical context to neurology research by transforming unstructured notes into validated variables, including disease severity, treatment response, cognitive testing, seizure frequency, stroke severity, imaging interpretation, and longitudinal outcomes.

Linked and research-ready with structured EHR data and continuous patient timelines, these variables enable precise study of complex neurologic conditions, including neurodegenerative and rare diseases.

sample epilepsy patient note
Analyze the full neurologic patient journey with validated variables from notes.

Build AI and see disease progression with integrated neuroimaging

Evaluate complete clinical context with longitudinal neuroimaging that is longitudinally integrated with structured and unstructured EHR data to:

Adjudicate clinical outcomes
Build and validate AI models
Confirm device placement
Evaluate treatment response
Visualize neurologic disease progression
Medical imaging viewer showing CT brain scans in coronal and sagittal views with measurement markers highlighting a region of interest

Analyze brain imaging to build diagnostic AI and understand neurologic disease progression and real-world effectiveness.

From foundational research to regulatory and clinical impact

AI training

Develop AI multimodal models using longitudinal neurologic data, including clinical notes and neuroimaging to detect disease patterns and progression

Clinical trials

Shorten development timelines by identifying eligible neurology patients faster

Therapy adoption

Empower field teams with real-time data and differentiated evidence

Safety

Detect neurologic adverse events and safety signals earlier

Outcomes research

Evaluate clinical and economic outcomes using complete neurologic patient journeys